Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China · Delayed Price · Currency is CNY 44.56
-0.31 (-0.69%)
At close: Jun 23, 2026
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 4.86 billion as of June 23, 2026. Its market cap has increased by 150.95% in one year.
Market Cap
4.86B
Enterprise Value
4.10B
Revenue
197.68M
Ranking
n/a
PE Ratio
83.80
Stock Price
44.56
Market Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 4.86B, a decrease of -18.86%. That is a compound annual growth rate of -4.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 4.86B | 106.11% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
| Mar 11, 2022 | 5.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 5.70B |
| Hangzhou Biotest Biotech | 5.59B |
| Shanghai OPM Biosciences | 5.30B |
| Jiangsu Aidea Pharmaceutical Group | 5.29B |
| Anhui Huaheng Biotechnology | 5.20B |
| Novogene | 5.06B |
| Shenzhen Weiguang Biological Products | 5.03B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.82B |